Consuela A. Albright: Clinical Advocacy in Sickle Cell Disease
Consuela A. Albright, Nurse Practitioner at Cleveland Clinic, shared a post on LinkedIn:
“Advocacy isn’t only the work of patient organizations, it’s also the responsibility of the clinical and research community.
The American Society of Hematology (ASH) is the world’s largest professional society for blood disorder specialists, and sickle cell disease has long been a core focus of its advocacy arm.
ASH advocates for sustained NIH and NHLBI research funding, supports policies that expand access to emerging treatments and curative therapies, and works to build a hematology workforce that reflects the communities most affected by SCD.
As a clinician, I feel this aspect of advocacy most directly: the responsibility to translate bedside experience into policy input and to ensure the people setting research priorities hear from those providing day to day care.
Advocacy from the clinical side doesn’t replace patient led advocacy it should amplify it.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026